Skip to main content

Table 4 The effect of the relevant significant variables on clinical outcomes

From: The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study

 

CPR Adj-OR (95%CI)

p

MR Adj-OR (95%CI)

p

LBR Adj-OR (95%CI)

p

Maternal age at ETa

0.71 (0.46–1.10)

0.125

0.94 (0.42- 2.12)

0.884

0.84 (0.50–1.42)

0.523

Maternal age at ART starta

1.18 (0.77–1.82)

0.448

1.44 (0.65–3.15)

0.368

0.97 (0.58–1.64)

0.914

AMHa

0.81 (0.41–1.63)

0.561

0.78 (0.17–3.47)

0.739

0.98 (0.44–2.17)

0.955

Strategyb

 

0.478

 

0.036*

 

0.022*

Fresh IVF

1

 

1

 

1

 

Accumulated vitrified M-II

0.80 (0.44–1.48)

0.478

4.00 (1.10–14.58)

0.036*

0.42 (0.20–0.89)

0.022*

Number of Embryos transferredb

 

 < 0.001*

 

0.327

 

0.013*

1

1

 

1

 

1

 

2

4.23 (1.80–9.97)

0.001*

0.00 (0.00-Inf)

0.99

3.40 (1.41–8.18)

0.006*

3

6.48 (2.67–15.72)

 < 0.001*

0.00 (0.00-Inf)

0.99

3.19 (1.25–8.10)

0.015*

4

9.07 (3.30–24.91)

 < 0.001*

0.00 (0.00-Inf)

0.99

5.94 (1.99–17.71)

0.001*

  1. Linear regression was used to analyze continuous variables and logistic regression was used to evaluate categorical variables. Each variable was adjusted for the strategy for managing DOR, AMH, the number of embryos transferred, ET day, maternal age at ET, and ART start. Abbreviations: CPR clinical pregnancy rate, MR miscarriage rate, LBR live birth rate, ET embryo transfer, ART assisted reproduction technology, AMH Anti-Müllerian hormone, IVF in vitro fertilization, M-II metaphase II, ET embryo transfer
  2. *p < 0.05
  3. aContinuous variables
  4. bCategorical variables